Abstract
Pancreatic ductal adenocarcinoma (PDAC) is a gastrointestinal malignancy with a dismal clinical outcome. Accumulating evidence suggests that activated pancreatic stellate cells (PSCs), the major producers of extracellular matrix (ECM), drive the severe stromal/desmoplastic reaction in PDAC. Furthermore, the crosstalk among PSCs, pancreatic cancer cells (PCCs) as well as other stroma cells can establish a growth-supportive tumor microenvironment (TME) of PDAC, thereby enhancing tumor growth, metastasis, and chemoresistance via various pathways. Recently, targeting stroma has emerged as a promising strategy for PDAC therapy, and several novel strategies have been proposed. The aim of our study is to give a profound review of the role of PSCs in PDAC progression and recent advances in stroma-targeting strategies.
| Item Type: | Journal article |
|---|---|
| Keywords: | Pancreatic stellate cells, pancreatic ductal adenocarcinoma, tumor microenvironment, stroma-targeting strategy, tumor therapy |
| Faculties: | Medicine |
| Subjects: | 600 Technology > 610 Medicine and health |
| URN: | urn:nbn:de:bvb:19-epub-103168-1 |
| ISSN: | 2234-943X |
| Language: | English |
| Item ID: | 103168 |
| Date Deposited: | 05. Jun 2023 15:42 |
| Last Modified: | 07. Dec 2023 16:53 |

